Every factual claim on HairMaxxProtocol.com is supported by peer-reviewed research. Citations are formatted to APA 7th edition. DOI links point to the original published source.
← Back to ProtocolSeminal case study of pseudohermaphrodites in the Dominican Republic with 5α-reductase deficiency. Established the enzyme's essential role in converting testosterone to DHT and defined the biological conversion pathway.
Established that DHT has 5–10× greater binding affinity for the androgen receptor compared to testosterone, explaining its disproportionate physiological impact at lower serum concentrations.
Demonstrates that shorter CAG repeats in the AR gene produce a more transcriptionally active androgen receptor, making follicles more sensitive to DHT. Explains why two men with identical DHT levels can have completely different hair loss outcomes.
Large multicenter double-blind RCT confirming 1mg/day finasteride reduces serum DHT by approximately 70% without lowering testosterone, and significantly improves hair count vs placebo over 2 years.
Reviews androgen action in muscle. Demonstrates skeletal muscle inactivates DHT via 3α-hydroxysteroid dehydrogenase (3α-HSD) before it can bind androgen receptors — explaining why blocking DHT conversion does not impair muscle hypertrophy.
Establishes EGCG from green tea as a competitive inhibitor of both Type I and Type II 5α-reductase isoforms. Provides the mechanistic basis for green tea's inclusion in natural DHT management protocols.
Double-blind placebo-controlled RCT (n=76) showing 40% increase in hair count with 400mg/day pumpkin seed oil vs 10% in the placebo group at 24 weeks. The only natural DHT-blocking supplement with an RCT specifically for androgenetic alopecia.
Small RCT (n=20) in which a creatine loading protocol increased the DHT:testosterone ratio by 56% during the loading phase vs placebo. This finding has not been consistently replicated at standard maintenance doses in larger or more diverse cohorts.
RCT showing one week of sleep restriction to 5 hours per night reduced daytime testosterone by 10–15% in healthy young men. Testosterone was lowest in the afternoon following restricted sleep. Supports the 7–9 hour sleep recommendation.
Systematic review across 17 clinical trials confirming a consistently favourable tolerability profile for saw palmetto, with mild transient gastrointestinal effects as the primary adverse events. Supports safety profile for long-term DHT inhibition use.
Demonstrates zinc supplementation in deficient males increases plasma testosterone. Provides mechanistic evidence for zinc as a natural modulator of testosterone production. Particularly relevant for men with insufficient dietary zinc intake.
RCT (n=165) showing 3332 IU/day Vitamin D3 supplementation significantly increased total testosterone (+25%) vs placebo (no change) over 12 months. Vitamin D receptors are present in Leydig cells; D3 plays a direct role in testosterone biosynthesis.
RCT examining a dual 5α-reductase inhibitor in combination with TRT. Demonstrates full preservation of lean body mass, muscle strength, and sexual function despite significant DHT reduction — key evidence that blocking DHT during testosterone therapy does not impair anabolic outcomes.
Network meta-analysis of 33 studies ranking treatments for male pattern hair loss. Found oral dutasteride 0.5 mg/day most effective overall, while among FDA-approved options topical minoxidil 5% and oral finasteride 1 mg/day remained first-line. Supports the Research Dispatch entry on relative treatment efficacy.
Review of current and emerging androgenetic alopecia therapies, including long-term finasteride and dutasteride outcomes, lower-dose dutasteride formulations, and investigational injectable and siRNA-based approaches. Supports the Research Dispatch entries on multi-year efficacy and trial-stage treatments.
Review of regenerative hair-loss therapies — stem cells, hair follicle cells, growth factors, extracellular vesicles, and gene therapy. Basis for the Research Dispatch entries flagged as investigational and not yet clinically available.
Review synthesizing the population-level (NHANES, Air Force, Nordic cohort) decline in testosterone of roughly 0.5–1.0%/year, independent of aging. Identifies obesity, sleep disruption, diet, endocrine-disrupting chemicals, and medications as contributors. Source for the Research Dispatch testosterone-decline, sleep, and endocrine-disruptor entries.
Cross-sectional study of 50 young men (mean age 20.7) identifying hypertrophy training and sunlight exposure as positive testosterone predictors, and sleep deprivation, tobacco, junk food, and carbonated beverages as negative ones. Small observational sample — basis for the Research Dispatch lifestyle-predictor entry, reported as associations only.
Audit of 50 testosterone-boosting supplements found only 24.8% had data supporting their claims, despite 90% making them. Supports the Research Dispatch entry on the weak evidence base behind T-booster products and the site's skeptical grading of supplements.
Meta-analysis of 7 RCTs (N=396) finding topical minoxidil + finasteride significantly superior to minoxidil alone for hair density (MD +9.22) and diameter (MD +2.26), with no treatment-emergent sexual side effects and plasma finasteride below 1 ng/mL. Supports the Research Dispatch entry on combination topical therapy.
Systematic review (9 studies) finding dutasteride 0.5–2.5 mg significantly more effective than finasteride 1 mg for hair count, with comparable adverse-event rates. Basis for the Research Dispatch entry on dutasteride's larger effect size; dutasteride remains off-label for AGA in the US.
Systematic review of 9 studies (N=381) reporting saw palmetto improved hair quality in 60% and total hair count by 27%, while being inferior to finasteride in the only direct comparison and noting that robust high-quality data are lacking. Supports the Research Dispatch entry quantifying natural DHT blockers and grading their evidence as low.
Meta-analysis showing weight loss (via low-calorie diet or bariatric surgery) significantly raises total and free testosterone, with the degree of weight loss the best determinant of the rise. Source for the Research Dispatch entry ranking weight loss as the strongest natural lever on testosterone.
Randomized trial showing magnesium status and supplementation modulate vitamin D status and metabolism — the activating hydroxylase enzymes are magnesium-dependent. Supports the Research Dispatch entry on why vitamin D supplementation can underperform without adequate magnesium.